Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers
Background Polyhexamethylene biguanide (PHMB) eye drops are a frequently used medication to treat Acanthamoeba keratitis. In the absence of marketed PHMB eye drops, pharmacy-compounding units are needed to prepare this much needed treatment, but the lack of validated PHMB stability data severely lim...
Main Authors: | Yassine Bouattour, Philip Chennell, Mathieu Wasiak, Mireille Jouannet, Valérie Sautou |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2018-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/4549.pdf |
Similar Items
-
Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan
by: Fu-Chin Huang, et al.
Published: (2017-10-01) -
Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
by: Huang Jian-Ming, et al.
Published: (2021-01-01) -
The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage
by: Fu-Chin Huang, et al.
Published: (2016-12-01) -
Double-Biguanide Therapy for Resistant Acanthamoeba Keratitis
by: Giulio Ferrari, et al.
Published: (2011-11-01) -
Diagnosis and Treatment of Acanthamoeba Keratitis
by: Lincoln Lavado Landeo
Published: (2015-10-01)